Donovan, K., Herrington, W., Haynes, R., Sardell, R., Baigent, C., Holmes, M., & Staplin, N. (2022). Fibroblast growth factor-23 and risk of cardiovascular diseases: A Mendelian randomization study. American Society of Nephrology.
芝加哥风格引文Donovan, K., W. Herrington, R. Haynes, R. Sardell, C. Baigent, M. Holmes, 与 N. Staplin. Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. American Society of Nephrology, 2022.
MLA引文Donovan, K., et al. Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. American Society of Nephrology, 2022.
警告：这些引文格式不一定是100％准确.